Quincy, MA, United States of America

Mansoureh Rezaei



 

Average Co-Inventor Count = 21.5

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mansoureh Rezaei

Introduction

Mansoureh Rezaei is a notable inventor based in Quincy, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of four patents to her name, her work has the potential to impact various medical conditions.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Heteroaryls and uses thereof." This patent presents a compound of formula I and pharmaceutically acceptable salts thereof, where specific variables are defined in the specification. These compounds serve as inhibitors of VPS34, making them useful for treating proliferative, inflammatory, or cardiovascular disorders. This innovation highlights her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Mansoureh has worked with prominent companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited and Takeda Pharmaceutical Company Limited. Her experience in these organizations has allowed her to develop her expertise and contribute to significant advancements in drug development.

Collaborations

Throughout her career, Mansoureh has collaborated with talented individuals such as Indu T Bharathan and Chris Blackburn. These partnerships have likely enriched her work and fostered an environment of innovation.

Conclusion

Mansoureh Rezaei's contributions to the field of pharmaceuticals through her patents and collaborations demonstrate her dedication to innovation and improving healthcare. Her work continues to inspire future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…